Abbott recieves EU nod for balloon dilation catheter system
Abbott Laboratories has received European regulatory approval for its Trek and Mini-Trek coronary dilation balloon catheters, which are indicated for the treatment of coronary artery disease.
The Trek systems received CE mark in May 2010 and are used during angioplasty procedures to aid in the opening of patients’ narrowed coronary arteries.
According to the Abbott Park, Ill.-based company, the Trek RX system is available for use in Japan and the Trek RX and Trek OTW are now available for use in the U.S. The devices are available in two designs: the Mini-Trek (U.S. in 1.5 to 2 mm sizes and Japan, 1.2 to 2 mm) and the Trek system available in over 70 sizes and diameters (1.2mm to 5 mm) and lengths (6 mm to 30 mm).
With the latest approval, the devices are available for use in all worldwide markets.
The Trek systems received CE mark in May 2010 and are used during angioplasty procedures to aid in the opening of patients’ narrowed coronary arteries.
According to the Abbott Park, Ill.-based company, the Trek RX system is available for use in Japan and the Trek RX and Trek OTW are now available for use in the U.S. The devices are available in two designs: the Mini-Trek (U.S. in 1.5 to 2 mm sizes and Japan, 1.2 to 2 mm) and the Trek system available in over 70 sizes and diameters (1.2mm to 5 mm) and lengths (6 mm to 30 mm).
With the latest approval, the devices are available for use in all worldwide markets.